Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Clinical scales, based on the major signs of Parkinson's disease (PD), are commonly used to assess the effect of symptomatic treatment of PD. With the appearance of therapy aiming to rescue or protect the nigrostriatal neurons in PD, it becomes essential to define which of these signs best reflects the underlying neuronal deficit. Fluorodopa positron emission tomography has been shown to correlate with postmortem nigral cell counts. We correlated the major signs of PD with positron emission tomography results in 35 PD patients. We found that in the “practically defined off” state, (1) Purdue pegboard scores correlated best with the nigrostriatal dopaminergic deficit; (2) of the subscales of the modified Columbia score, the bradykinesia subscale correlated best; (3) rigidity and postural distrubance correlated less highly than bradykinesia, and their inclusion in a multiple regression did not improve the correlation of pegboard or bradykinesia scores alone; and (4) tremor did not correlate with the nigrostriatal dopaminergic deficit. We conclude that pegboard and bradykinesia scores represent the best clinical measures for studying the effect of treatment on the evolution of the nigrostriatal lesion of PD. Inclusion of other clinical signs provides additional information only for the study of functional impairments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Tests for comparing elements of a correlation matrix
Steiger, J. H. (1980) · Psychological Bulletin · doi:10.1037/0033-2909.87.2.245 · Cited by 4,621
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
LAWRENCE, D. G., & KUYPERS, H. G. J. M. (1968) · Brain · doi:10.1093/brain/91.1.1 · Cited by 1,285
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,221
Core assessment program for intracerebral transplantations (CAPIT)
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., & Watts, R. (1992) · Movement Disorders · doi:10.1002/mds.870070103 · Cited by 1,008
Unified Parkinson's disease rating scale characteristics and structure
Martínez‐Martín, P., Gil‐Nagel, A., Gracia, L. M., Gómez, J. B., Martínez‐Sarriés, J., Bermejo, F., & The Cooperative Multicentric Group (1994) · Movement Disorders · doi:10.1002/mds.870090112 · Cited by 796
LAWRENCE, D. G., & KUYPERS, H. G. J. M. (1968) · Brain · doi:10.1093/brain/91.1.15 · Cited by 787
Irreversible motor impairment in young addicts ? ephedrone, manganism or both?
Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Zjablov, G., Asser, T., & Aquilonius, S.-M. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00818.x · Cited by 665
Dopamine visualized in the basal ganglia of living man
Garnett, E. S., Firnau, G., & Nahmias, C. (1983) · Nature · doi:10.1038/305137a0 · Cited by 644
Criteria for diagnosing Parkinson's disease
Calne, D. B., Snow, B. J., & Lee, C. (1992) · Annals of Neurology · doi:10.1002/ana.410320721 · Cited by 628
Self-citationBrooks, D. J., Ibanez, V., Sawle, G. V., Quinn, N., Lees, A. J., Mathias, C. J., Bannister, R., Marsden, C. D., & Frackowiak, R. S. J. (1990) · Annals of Neurology · doi:10.1002/ana.410280412 · Cited by 626
Parkinson's Disease and Movement Disorders
Kieburtz, K. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540220013003 · Cited by 616
Playford, E. D., Jenkins, I. H., Passingham, R. E., Nutt, J., Frackowiak, R. S. J., & Brooks, D. J. (1992) · Annals of Neurology · doi:10.1002/ana.410320206 · Cited by 611
The metabolic topography of parkinsonism
Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D., Przedborski, S., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.99 · Cited by 455
Jenkins, I. H., Fernandez, W., Playford, E. D., Lees, A. J., Frackowiak, R. S. J., Passingham, R. E., & Brooks, D. J. (1992) · Annals of Neurology · doi:10.1002/ana.410320608 · Cited by 419
Leenders, K. L., Salmon, E. P., Tyrrell, P., Perani, D., Brooks, D. J., Sager, H., Jones, T., Marsden, C. D., & Frackowiak, R. S. J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120034007 · Cited by 376
Snow, B. J., Tooyama, I., McGeer, E. G., Yamada, T., Calne, D. B., Takahashi, H., & Kimura, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340304 · Cited by 336
Self-citationDementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
Rinne, J. O., Mlic, J. R., Paljärvi, L., & Rinne, U. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260107 · Cited by 331
Interrater reliability of the unified Parkinson's disease rating scale motor examination
Richards, M., Marder, K., Cote, L., & Mayeux, R. (1994) · Movement Disorders · doi:10.1002/mds.870090114 · Cited by 318
Nigrostriatal function in humans studied with positron emission tomography
Martin, W. R. W., Palmer, M. R., Patlak, C. S., & Calne, D. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260407 · Cited by 282
Self-citationRescue of dying neurons: A new action for deprenyl in MPTP parkinsonism
Tatton, W. G., & Greenwood, C. E. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300410 · Cited by 272
THE BEREITSCHAFTSPOTENTIAL IS ABNORMAL IN PARKINSON'S DISEASE
DICK, J. P. R., ROTHWELL, J. C., DAY, B. L., CANTELLO, R., BURUMA, O., GIOUX, M., BENECKE, R., BERARDELLI, A., THOMPSON, P. D., & MARSDEN, C. D. (1989) · Brain · doi:10.1093/brain/112.1.233 · Cited by 268
BROOKS, D. J., SALMON, E. P., MATHIAS, C. J., QUINN, N., LEENDERS, K. L., BANNISTER, R., MARSDEN, C. D., & FRACKOWIAK, R. S. J. (1990) · Brain · doi:10.1093/brain/113.5.1539 · Cited by 256
Vingerhoets, F. J. G., Snow, B. J., Lee, C. S., Schulzer, M., Mak, E., & Calne, D. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360512 · Cited by 218
Self-citationEidelberg, D., Moeller, J. R., Dhawan, V., Sidtis, J. J., Ginos, J. Z., Strother, S. C., Cedarbaum, J., Greene, P., Fahn, S., & Rottenberg, D. A. (1990) · Movement Disorders · doi:10.1002/mds.870050304 · Cited by 204
Leenders, K. L., Poewe, W. H., Palmer, A. J., Brenton, D. P., & Frackowiak, R. S. J. (1986) · Annals of Neurology · doi:10.1002/ana.410200212 · Cited by 172
Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indices
Pate, B. D., Kawamata, T., Yamada, T., McGeer, E. G., Hewitt, K. A., Snow, B. J., Ruth, T. J., & Calne, D. B. (1993) · Annals of Neurology · doi:10.1002/ana.410340306 · Cited by 168
Self-citationClinical observations on the rate of progression of idiopathic parkinsonism
Lee, C. S., Schulzer, M., Mak, E., Snow, B. J., Tsui, J. K. C., Clane, S., Hammerstad, J. P., & Clane, D. B. (1994) · Brain · doi:10.1093/brain/117.3.501 · Cited by 147
Self-citationWhich Motor Disorder in Parkinson's Disease Indicates the True Motor Function of the Basal Ganglia?
Marsden, C. D. (1984) · Novartis Foundation Symposia · doi:10.1002/9780470720882.ch12 · Cited by 83
Regulation of DOPA Decarboxylase Activity in Brain of Living Rat
Cumming, P., Kuwabara, H., Ase, A., & Gjedde, A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031381.x · Cited by 76
Riemann, D., & Berger, M. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb06444.x · Cited by 73
Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
Vingerhoets, F. J. G., Snow, B. J., Schulzer, M., Morrison, S., Ruth, T. J., Holden, J. E., Cooper, S. D., & Calne, D. B. (1994) · PubMed · Cited by 73
Self-citationGarnett, E. S., Firnau, G., Chan, P. K. H., Sood, S. K., & Belbeck, L. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.464 · Cited by 71
A mathematical model of pathogenesis in idiopathic parkinsonism
Schulzer, M., Lee, C. S., Mak, E., Vingerhoets, F. J. G., & Calne, D. B. (1994) · Brain · doi:10.1093/brain/117.3.509 · Cited by 57
Self-citationGeminiani, G. C., Cesana, B. M., Tamma, F., Contri, P., Pacchetti, C., Carella, F., Piolti, R., Martignoni, E., Giovannini, P., Girotti, F., et al. (1991) · Movement Disorders · doi:10.1002/mds.870060411 · Cited by 56
Montgomery, G. K., Reynolds, N. C., & Warren, R. M. (1985) · Clinical Neuropharmacology · doi:10.1097/00002826-198503000-00009 · Cited by 55
Montgomery, G. K., Reynolds, N. C., & Warren, R. M. (1985) · PubMed · Cited by 47
Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease
Rinne, U. K., & Sonninen, V. H. (1972) · Neurology · doi:10.1212/wnl.22.1.62 · Cited by 46
Impaired activation of frontal areas during movement in Parkinson's disease : a PET study
Playford, E. D., Jenkins, I. H., Passingham, R. E., Frackowiak, R. S. J., & Brooks, D. J. (1993) · PubMed · doi:10.82444/warw.33722926 · Cited by 39
Research works printed but not linked: 10
- Duvoisin RC, 1971, Monamines noyaux gris centraux et syndrome de Parkinson, 313
- 10.1002/ana.410320614 · doi:10.1002/ana.410320614
- 10.1007/BF01945762 · doi:10.1007/bf01945762
- 10.1111/j.2042-7158.1976.tb02801.x · doi:10.1111/j.2042-7158.1976.tb02801.x
- 10.1016/0006-8993(83)91187-3 · doi:10.1016/0006-8993(83)91187-3
- Hietanen M, 1987, The pegboard as a measurement of parkinsonian deficit, Neurology, 37, 266
- 10.1111/j.1600-0404.1990.tb00926.x · doi:10.1111/j.1600-0404.1990.tb00926.x
- Vingerhoets FJG, 1994, Reproducibility of the fluorodopa positron tomography indices in Parkinson's disease, Mov Disord, 9, 119
- VingerhoetsFJG SchulzerM SnowBJ. Clinical and [18F]‐6‐fluorodopa PET correlations in Parkinson's disease: a comparison of 5 methods of PET analysis.J Cereb Blood Flow Metab1995(in press) (Abstract)
- 10.1007/BF02260914 · doi:10.1007/bf02260914
Cited by
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Thenganatt, M. A., & Jankovic, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6233 · Cited by 506
EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12022 · Cited by 489
Metadata
- Authors
- Vingerhoets, F. J. G., Schulzer, M., Calne, D. B., & Snow, B. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1997-01
- Volume
- 41
- Issue
- 1
- Pages
- 58-64
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2147041299
- Cited by
- 359
- References
- 42
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.